Hirsutism: From Brazil to a Place Near You

    January 2010 in “ Expert Opinion on Pharmacotherapy
    Anousha Yazdabadi, Rodney Sinclair
    Image of study
    TLDR No treatment fully stops excessive hair growth in women, but various methods can help manage it effectively.
    The document reviewed treatments for hirsutism, a condition of excessive hair growth in women, and concluded that while no treatment guarantees complete permanent hair removal, various options can manage the condition. Topical eflornithine and hand-held laser hair removal devices were noted for their effectiveness, particularly when used together. Oral antiandrogens, such as spironolactone, cyproterone acetate, finasteride, and oral contraceptives, were found to reduce excess hair by about one-third and are most effective when used long-term or in combination, with the choice often based on side effects and patient characteristics. Insulin sensitizers like metformin were deemed less beneficial. Despite the availability of these treatments, the permanent resolution of hirsutism remains elusive.
    Discuss this study in the Community →

    Research cited in this study

    19 / 19 results

    Related Community Posts Join

    6 / 24 results

      community Bile Acid-Mediated DHT Dysregulation Hypothesis

      in Research/Science  13 upvotes 2 weeks ago
      Elevated bile acids can inhibit the enzyme AKR1C2, leading to increased DHT levels, which may accelerate hair loss in those predisposed to androgenetic alopecia. Treatments mentioned include topical minoxidil and finasteride.

      community Spironolactone or bicalutamide prescription

      in Treatment  4 upvotes 1 year ago
      The conversation is about someone seeking a doctor in the EU who prescribes spironolactone or bicalutamide for female pattern hair loss, as they are having difficulty finding treatment options beyond Minoxidil in Austria. They are asking for recommendations and are open to direct messages for assistance.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

    Related Research

    5 / 5 results